ristol-Myers Squibb Pharmaceutical esearch Institute

نویسنده

  • Laurie Smaldone
چکیده

Bristol-Myers Squibb is a diversified worldwide health and personal care company with principal businesses in pharmaceuticals, consumer medicines, nutritionals and medical devices. We are a leader in the research and development of innovative therapies for cardiovascular, metabolic and infectious diseases, neurological disorders, and oncology. In 2001 alone, Bristol-Myers Squibb dedicated $2.1 billion for pharmaceutical research and development activities. The company has nearly 6,000 scientists and doctors committed to discover and develop best in class therapeutic and preventive agents that extend and enhance human life. Our current pipeline comprises more than 50 compounds under active development.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.

Bristol Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08534, Bristol-Myers Squibb, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, Bristol Myers Squibb, Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543, and Bristol-Myers Squibb, Pharmaceutical Research Institute, One Squibb Drive, New Bru...

متن کامل

Introduction: the art and science of switching antipsychotic medications.

From the Department of Psychiatry, Medical College of Georgia, Augusta. The curriculum roundtable “The Art and Science of Switching Antipsychotic Medications” was held January 21, 2006, in Atlanta, Ga., and supported by an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. Dr. Buckley is a consultant for Abbott, Alamo, AstraZeneca, Bristol-Myers Squibb, ...

متن کامل

BRIEF COMMUNICATIONS PREVENTION OF CHRONIC REJECTION IN MOUSE AORTIC ALLOGRAFTS BY COMBINED TREATl\IENT WITH CTLA4-IG AND ANTI-CD40 LIGAND MONOCLONAL ANTIBODy1,2

Thomas E. Stanl Transplantation Institute, Section of Cellular Transplantation. and Departments of Surgery and Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261; Laboratory of Immunogenetics and Transplantation. Brigham and Women's Hospital, Harvard Medical School. Boston, Massachusetts 02115; and Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, ...

متن کامل

Carbapenem-Resistant Strain of Klebsiella oxytoca Harboring Carbapenem-Hydrolyzing -Lactamase KPC-2

Carbapenem-Resistant Strain of Klebsiella oxytoca Harboring Carbapenem-Hydrolyzing -Lactamase KPC-2 Hesna Yigit, Anne Marie Queenan, J. Kamile Rasheed, James W. Biddle, Antonio Domenech-Sanchez, Sebastian Alberti, Karen Bush, and Fred C. Tenover* Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492; The R. W. Johnson Pharmaceutical Research Institute, Raritan, ...

متن کامل

Cancer Immunity (20 October 2010) Vol. 10, p. 9

1Memorial Sloan-Kettering Cancer Center, New York, USA 2H. Lee Moffitt Cancer Center, Tampa, FL, USA 3The Angeles Clinic and Research Institute, Santa Monica, CA, USA 4AP-HP, Hôpital Saint-Louis, Service de Dermatologie; Université Paris Diderot Paris7, INSERM U976 Skin Research Center, Paris, France 5University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy 6University Hospital Essen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002